Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Irvine, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Eledon Pharmaceuticals, Inc. has filed 608 SEC EDGAR filings since 18 Jun 2007

SEC filing history

Showing 476-500 of 605 matching filings.

Per page
25
Current page
20
4

PRIMARY DOCUMENT

Filing date
16 Jun 2016
Reporting date
15 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
16 Jun 2016
Reporting date
15 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
16 Jun 2016
Reporting date
15 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36620

FORM 8-K

Filing date
16 Jun 2016
Reporting date
15 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36620

FORM 8-K

Filing date
31 May 2016
Reporting date
27 May 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-36620

CT ORDER filing

Filing date
16 May 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-36620

DEFA14A

Filing date
29 Apr 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36620

DEF 14A

Filing date
29 Apr 2016
Reporting date
15 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
15 Mar 2016
Reporting date
15 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
IRANNOTICE File 001-36620

IRANNOTICE

Filing date
10 Mar 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-210058

S-8

Filing date
10 Mar 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88334

AMENDMENT NO.1 TO FORM SC 13G

Filing date
12 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88334

SC 13G/A

Filing date
10 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 Jan 2016
Reporting date
08 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36620

FORM 8-K

Filing date
07 Jan 2016
Reporting date
07 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Dec 2015
Reporting date
15 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Dec 2015
Reporting date
15 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Dec 2015
Reporting date
15 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Dec 2015
Reporting date
15 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Dec 2015
Reporting date
15 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Nov 2015
Reporting date
11 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-207359

EFFECT filing

Filing date
23 Oct 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .